Drug & intervention
ibalizumab
RxCUI 2043283
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
3 shownIbalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1NCT02707861 · 2016-03-01
COMPLETEDCompassionate Use of Ibalizumab for the Treatment of HIV InfectionNCT02028819 · 2012-01-01
NO_LONGER_AVAILABLEDose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1NCT00784147 · 2008-08-01
COMPLETEDConditions being studied
Research locations
ChicagoIllinois, United States2DallasTexas, United States2DenverColorado, United States2GreenvilleNorth Carolina, United States2HoustonTexas, United States2Long BeachCalifornia, United States2Los AngelesCalifornia, United States2MiamiFlorida, United States2New YorkNew York, United States2OrlandoFlorida, United States2San FranciscoCalifornia, United States2San JuanPuerto Rico2
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.